Clinical trial
Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection
NCT00594880 is registered in ClinicalTrials.gov with The Wistar Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection
- Lead sponsor
- The Wistar Institute
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2008
- Completion date
- May 31, 2011
- Enrollment
- 23 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.